HAS Healthcare Advanced Synthesis SA
PrivateLast Round
Private Equity
Mar 31, 2025
Est. Valuation
$380M
Total Funding Raised
$152M
Company Overview
HAS Healthcare Advanced Synthesis SA operates in Healthcare & Life Sciences and is based in Biasca. Its latest recorded funding round was a Private Equity round in March 2025.
HAS Healthcare Advanced Synthesis SA is a pharmaceutical company that develops and manufactures active pharmaceutical ingredients (APIs), highly potent APIs (HPAPIs), and anticancer compounds for the pharmaceutical and biotechnology industries.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Pharma Supply Chain, Precision Medicine, Compliance
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
HAS Healthcare Advanced Synthesis SA Comparables
Compare HAS Healthcare Advanced Synthesis SA with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axplora | 87% | |
| Sterling Pharma Solutions | 86% | |
| CordenPharma | 83% |
For institutional investors. Book with your work email.
HAS Healthcare Advanced Synthesis SA Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
HAS Healthcare Advanced Synthesis SA Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| 65 Equity Partners | Private Equity |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 22, 2026
Monthly visitors increased 44% MoM.
- Apr 4, 2026
Monthly visitors increased 133% MoM.
For institutional investors. Book with your work email.
HAS Healthcare Advanced Synthesis SA Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about HAS Healthcare Advanced Synthesis SA's valuation, stock price, and market status.
Is HAS Healthcare Advanced Synthesis SA a public or private company?
HAS Healthcare Advanced Synthesis SA is a private company.
What is the current stock price of HAS Healthcare Advanced Synthesis SA?
HAS Healthcare Advanced Synthesis SA is a private company, so its shares have no public market price. Caplight tracks HAS Healthcare Advanced Synthesis SA's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is HAS Healthcare Advanced Synthesis SA worth (valuation)?
HAS Healthcare Advanced Synthesis SA's valuation is estimated at $380.0M based on funding round data.
Can I buy HAS Healthcare Advanced Synthesis SA stock?
HAS Healthcare Advanced Synthesis SA shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was HAS Healthcare Advanced Synthesis SA's last funding round?
HAS Healthcare Advanced Synthesis SA's most recent funding round was Private Equity on March 31, 2025.
Who are the main investors in HAS Healthcare Advanced Synthesis SA?
Key investors in HAS Healthcare Advanced Synthesis SA include 65 Equity Partners.
Will HAS Healthcare Advanced Synthesis SA IPO soon?
No public IPO plans have been announced for HAS Healthcare Advanced Synthesis SA.
How can I track HAS Healthcare Advanced Synthesis SA secondary market activity?
Caplight tracks bids, offers, and trades in HAS Healthcare Advanced Synthesis SA's shares on secondary markets.